arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Ovid Therapeutics Inc.

OVID Health Care Biotechnology: Pharmaceutical Preparations
$2.16
▼ -12.6% Today
as of Oct 23, 16:51 ET
Last 30 days -21.17% Sep 14 → Oct 23
$2.10 $2.28 $2.46 $2.63 $2.81 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.31
High
$2.31
Low
$2.12
Volume
$2M
Avg Vol
$2M
Mkt Cap
$475M
P/E (TTM)
—
Beta
—
52w High
$3.10
52w Low
$1.18
Div Yield
—
Shares Out
$185M

Recent Press Releases & News last 60 days · 4 items

Oct 8 · 09:13 Simply Wall St.
Ovid Therapeutics (OVID) Stock Gets Fair Value Boost As Analysts Focus On OV329
Oct 6 · 11:25 MT Newswires
Guggenheim Initiates Ovid Therapeutics at Buy
Sep 12 · 10:46 Insider Monkey
Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two
▸ Show all 4 press releases & news Free account →

OVID earnings at a glance

The options market is pricing a move of about ±15.0% after the report, a range of roughly $1.84 to $2.48 from today's $2.16. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.1% on average; after the most recent report on May 12, 2026 it moved +2.9%. That means options currently expect more movement than OVID has typically delivered. OVID beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 127%. The share price of $2.16 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.18
$3.10
51% of range
Avg surprise (last 4)
+12.3%
Avg reaction (last 2)
-1.2%
50% positive
Latest IV / EM
127%
EM ±15.0% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.20$-0.12$-0.04$0.04$0.12 Actual $-0.19Actual $-0.18Actual $-0.16Actual $-0.17Actual $0.12Actual $-0.20Actual $-0.14Est $-0.14Actual $-0.06Est $-0.16Actual $-0.17Est $-0.15Actual $-0.12Est $-0.12 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-17M$-11M$-5M$692,200$7M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.12 $-0.12 0.0% +14.3% +2.9% earnings
Wed Nov 12, 2025Sep/2025 $-0.17 $-0.15 -13.3% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.06 $-0.16 +62.5% — — earnings
Tue May 13, 2025Mar/2025 $-0.14 $-0.14 0.0% — -5.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.20 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.12 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.17 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.16 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.18 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.19 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$733,000$0—$132,000$6M$130,000—$173,000
Cost of revenue————————
Gross profit————————
Operating income$-16M$-18M—$-13M$-5M$-13M—$-13M
Net income$-15M$-17M—$-12M$-5M$-10M—$-14M
EPS (diluted)———————$-0.20

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$11M$94M$13M$21M$28M$21M$26M$15M
Inventory————————
Total current assets$124M$160M$74M$29M$42M$46M$56M$66M
Total assets$232M$226M$151M$64M$77M$82M$92M$103M
Long-term debt————————
Total liabilities$22M$27M$20M$19M$22M$22M$24M$26M
Total equity$210M$198M$131M$45M$56M$59M$68M$76M

Implied volatility — last 90 days

51%168%286%404%521% Jun 16 — IV 502% · EM ±29.7%Jun 19 — IV 120% · EM ±26.4%Jun 22 — IV 192% · EM ±40.0%Jun 23 — IV 94% · EM ±19.1%Jun 24 — IV 121% · EM ±24.3%Jun 25 — IV 190% · EM ±37.2%Jun 26 — IV 164% · EM ±31.4%Jun 29 — IV 137% · EM ±24.4%Jun 30 — IV 173% · EM ±29.7%Jul 01 — IV 123% · EM ±20.5%Jul 02 — IV 116% · EM ±18.7%Jul 03 — IV 119% · EM ±18.6%Jul 07 — IV 207% · EM ±27.3%Jul 08 — IV 234% · EM ±29.3%Jul 10 — IV 183% · EM ±20.2%Jul 15 — IV 272% · EM ±16.1%Jul 21 — IV 134% · EM ±31.1%Jul 22 — IV 133% · EM ±30.5%Jul 23 — IV 195% · EM ±43.8%Jul 27 — IV 122% · EM ±25.5%Jul 28 — IV 207% · EM ±42.4%Jul 29 — IV 185% · EM ±37.1%Jul 31 — IV 271% · EM ±51.8%Aug 03 — IV 292% · EM ±51.8%Aug 04 — IV 75% · EM ±12.9%Aug 06 — IV 232% · EM ±37.5%Aug 07 — IV 207% · EM ±32.3%Aug 11 — IV 154% · EM ±20.3%Aug 12 — IV 263% · EM ±32.9%Aug 14 — IV 189% · EM ±20.9%Aug 17 — IV 290% · EM ±24.2%Aug 18 — IV 243% · EM ±17.6%Aug 19 — IV 522% · EM ±30.8%Aug 25 — IV 185% · EM ±37.8%Aug 26 — IV 208% · EM ±41.7%Aug 27 — IV 166% · EM ±32.4%Aug 28 — IV 174% · EM ±33.3%Aug 31 — IV 180% · EM ±31.8%Sep 01 — IV 186% · EM ±32.1%Sep 04 — IV 194% · EM ±30.4%Sep 07 — IV 219% · EM ±30.4%Sep 08 — IV 230% · EM ±30.4%Sep 21 — IV 88% · EM ±18.4%Sep 22 — IV 168% · EM ±34.4%Sep 24 — IV 51% · EM ±10.0%Sep 25 — IV 98% · EM ±18.8%Sep 28 — IV 56% · EM ±10.0%Oct 02 — IV 108% · EM ±16.8%Oct 05 — IV 121% · EM ±16.8%Oct 06 — IV 96% · EM ±12.7%Oct 07 — IV 102% · EM ±12.8%Oct 08 — IV 127% · EM ±15.0%

Sector peers

EVMN
Evommune, Inc.
$472M $5.10-1.4%
ARVN
Arvinas, Inc.
$487M $7.30-3.4%
DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%
ACRS
Aclaris Therapeutics, Inc.
$500M $3.75-1.6%
CBIO
Crescent Biopharma, Inc.
$501M $12.82-2.7%
PBYI
Puma Biotechnology Inc
$506M $11.02+1.1%

OVID earnings FAQ

What is OVID's expected move for earnings?

Options currently price a move of about ±15.0%, or $0.32 per share either way from $2.16.

How does OVID stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.1%, up 1 times and down 1 times.

What is OVID's implied volatility?

OVID's at-the-money implied volatility is about 127% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in